FIELD: pharmaceuticals.
SUBSTANCE: group of inventions relates to the field of pharmaceuticals, namely to a humic agent exhibiting anti-inflammatory activity and an application thereof for treatment and/or prevention of inflammatory diseases. The humic agent exhibiting anti-inflammatory activity is produced from leonardite, lignin, coal, peat, sapropel, by means of ultrasonic dispersion of the pre-ground raw materials in a mixture with water at a certain temperature and a certain pressure, followed by cooling the solution to room temperature and diluting with water until reaching a content of humic substances of 1 to 20% wt., wherein the humic substances include humic and fulvic acids and salts thereof, as well as hydroquinone in an amount not exceeding 3% wt. of the weight of the humic substances.
EFFECT: group of inventions ensures production of a humic agent exhibiting anti-inflammatory activity, containing a wide range of humic substances and containing no chemical impurities, usable in the field of medicine and pharmaceuticals.
2 cl, 2 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
IMMUNOMODULATING HUMIC AGENT | 2020 |
|
RU2756353C1 |
ANTIBACTERIAL HUMIC AGENT | 2020 |
|
RU2753606C1 |
ANTIVIRAL HUMIC AGENT | 2020 |
|
RU2753609C1 |
ANTICOAGULATION HUMIC AGENT FOR IMPROVING RHEOLOGICAL PROPERTIES OF BLOOD | 2020 |
|
RU2756364C1 |
DETOXIFYING HUMIC AGENT | 2020 |
|
RU2756354C1 |
METHOD OF PRODUCING HUMIC SUBSTANCE EXTRACT | 2019 |
|
RU2720308C1 |
HEPATOPROTECTIVE HUMIC AGENT | 2021 |
|
RU2763761C1 |
ADAPTOGENIC HUMIC AGENT | 2021 |
|
RU2775079C1 |
HUMIC PREPARATION AND METHOD FOR PRODUCTION THEREOF | 2019 |
|
RU2717659C1 |
METHOD FOR PREVENTION OF GASTRIC MUCOSA ULCERATION | 2011 |
|
RU2481111C1 |
Authors
Dates
2021-09-29—Published
2020-10-16—Filed